• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Paediatr . Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and ti

tetano

Editor, Senior Moderator
Acta Paediatr


. 2021 Jul 31.
doi: 10.1111/apa.16051. Online ahead of print.
Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis


Ulla Koskela[SUP] 1 2 3 [/SUP], Otto Helve[SUP] 4 [/SUP], Emmi Sarvikivi[SUP] 4 [/SUP], Merja Helminen[SUP] 5 [/SUP], Tea Nieminen[SUP] 6 [/SUP], Ville Peltola[SUP] 7 [/SUP], Marjo Renko[SUP] 8 [/SUP], Harri Saxén[SUP] 6 [/SUP], Hanna Pasma[SUP] 1 [/SUP], Tytti Pokka[SUP] 1 [/SUP], Minna Honkila[SUP] 1 2 [/SUP], Terhi Tapiainen[SUP] 1 2 [/SUP]



Affiliations

Abstract

Aim: We investigated whether the ongoing COVID-19 pandemic was associated with the occurrence of Kawasaki disease or with multi-inflammatory syndrome in children (MIS-C).
Methods: This national Finnish register-based study was based on laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, MIS-C and Kawasaki disease cases. We performed a time series analysis on the occurrence of Kawasaki disease in 2016-2020.
Results: In 2020, there were 5,170 laboratory-confirmed COVID-19 cases in children under 18 years of age and five fulfilled the MIS-C case definition. The occurrence of MIS-C was 0.97 per 1,000 (95% confidence interval 0.31- 2.26) laboratory-confirmed SARS-CoV-2 infections in children. Our time series analysis showed that Kawasaki disease cases decreased during the COVID-19 pandemic. The seasonally adjusted incidence rate ratio was 0.49 (95% confidence interval 0.32-0.74) when it was compared to pre-pandemic levels. This coincided with a reduced occurrence of respiratory infections, due to social distancing in the population.
Conclusion: This nationwide register-based study found that MIS-C was a rare complication of the SARS-CoV-2 infection. The occurrence of Kawasaki disease and respiratory infections decreased during the pandemic. This suggests that transmissible microbes may play an important role in Kawasaki disease and social distancing may have a protective effect.

Keywords: Kawasaki disease; epidemiology; multi-inflammatory syndrome in children; social distancing; transmissible microbes.
 
Back
Top Bottom